PodcastIntel
Sign in Get Started Free
Metabolic Health Summit

Ozempic, Insulin Resistance, and Type 2 Diabetes: What Are We Missing? | Dr. Mariela Glandt

Jun 30, 2026 · 1:05:09
AI Summary
  • Dr. Mariela Glandt questions current type 2 diabetes treatment approaches.
  • She advocates for addressing underlying insulin resistance, not just blood sugar.
  • Takeaway: conventional diabetes care may be fundamentally flawed.

Guests on This Episode

MG
Mariela Glandt
1 podcast appearance

More from Metabolic Health Summit

View all episodes →

Get AI Summaries for Every New Episode

Subscribe to Metabolic Health Summit and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →